首页> Materials today. Bio> A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapy.

A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yichen,Liu

作者： Yichen,Liu ; Dahai,Hou ; Hui,Wang ; Qiuying,Yan ; Yunzhu,Xu ; Qibiao,Wu ; Dan,Dong ; Weixing,Shen ; Weiwei,Tao ; Haibo,Cheng ; Dongdong,Sun

关键词 Bufalin Colorectal cancer Immunotherapy M1 reprogramming Pyroptosis

DOI 10.1016/j.mtbio.2025.102527

PMID 41322154

发布时间 2025-12-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Materials today. Bio

2025年35卷

102527页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Materials today. Bio

2025年35卷

102527页

检索历史清除

A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapy.

Materials today. Bio

相似文献

同项目论文

Materials today. Bio

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A bufalin and CRISPR/Cas9 ribonucleoprotein-loaded calcium lactate nanomedicine for pyroptosis/apoptosis and synergistic cancer immunotherapy.

Materials today. Bio

相似文献

同项目论文

Materials today. Bio

相关期刊

检索历史清除